Ankur K. Mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ankur K. Mehta, Joint Managing Director and Promoter of CORONA Remedies Limited, has submitted a nil encumbrance declaration under SEBI (SAST) Regulations, 2011. The declaration confirms that neither Ankur Mehta nor any of his Persons Acting in Concert (PAC) have created any pledge or encumbrance on their equity shares — directly or indirectly — during the financial year 2025-2026. The filing lists 23 entities (including individual promoters, family members, and two LLPs) that form part of the PAC group. The declaration is dated April 01, 2026 and has been copied to the Chairman of the Audit Committee and the Company Secretary.
A nil encumbrance declaration is a positive signal for retail investors, as it indicates the promoter group has not borrowed against their shareholding, reducing the risk of forced selling pressure on the stock.